Skip to main content
ENGN
NASDAQ Life Sciences

Bladder Cancer Data Update Lifts Shares ~20%; Piper Upgrades to Overweight

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.21
Mkt Cap
$148.106M
52W Low
$1.4
52W High
$12.25
52W Position info
58% above low
Off High info
82% below high
Rel. Volume info
7.3× avg
Market data snapshot near publication time

ENGN sits 58% above its 52-week low of $1.4 on elevated volume (7.3× avg).

Summary

enGene's updated Phase 2 LEGEND Cohort 1 data for detalimogene in high-risk, BCG-unresponsive non-muscle invasive bladder cancer showed improvement across all efficacy endpoints versus the April analysis, based on an October 29 data cut. The 8-K filed this morning reported 56% complete response at any time and 43% estimated. Piper Sandler's Allison Bratzel upgraded the stock to Overweight from Neutral with a $4 target, writing that the data "looks a lot better than the May update" and clears uncertainty over the BLA filing package. Shares climbed nearly 20% on the session. The company plans to start regulatory submissions this year and target a full BLA filing in H1 2027, with potential FDA approval next year.

At the time of this announcement, ENGN was trading at $2.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $148.1M. The 52-week trading range was $1.40 to $12.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

ENGN - Latest Insights

ENGN
Nov 12, 2026, 6:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.89
Real-time Price: $2.24 info
Change: +$0.3488 (+18%) info
Market Cap: $150.036M info
ENGN
Nov 12, 2026, 1:39 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $1.82
Real-time Price: $2.24 info
Change: +$0.4188 (+23%) info
Market Cap: $150.036M info
ENGN
Sep 08, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.81
Real-time Price: $2.24 info
Change: +$0.4288 (+24%) info
Market Cap: $150.036M info
ENGN
Sep 08, 2026, 7:30 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $1.81
Real-time Price: $2.24 info
Change: +$0.4288 (+24%) info
Market Cap: $150.036M info
ENGN
Jul 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.82
Real-time Price: $2.24 info
Change: +$0.4188 (+23%) info
Market Cap: $150.036M info